NCT03065907View on ClinicalTrials.gov

Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

December 1, 2019

Conditions
Low VisionNeovascular Age-related Macular Degeneration
Interventions
OTHER

Vision rehabilitation

A service menu containing the minimum vision rehabilitation visits will be provided and assessed according to the participant's vision needs. Minimum vision rehabilitation visits include refraction, best-corrected visual acuity assessment, near vision, contrast sensitivity, central visual field test, education and consultation; rehabilitation visit will then be individualized.

Trial Locations (1)

21287

Wilmer Eye Institute, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT03065907 - Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy | Biotech Hunter | Biotech Hunter